SMC Decisions – 12 October 2026

The Scottish Medicines Consortium (SMC) published advice on eight medicines following its meeting on 12 October 2026.3 Six medicines were accepted for use on the NHS in Scotland; two were not recommended. Accepted for use References – Scotland 3. October 2026 decisions news release. Scottish Medicines Consortium. October 2026. https://scottishmedicines.org.uk/about-us/latest-update/october-2026-decisions-news-release/

SMC Decisions — 7 September 2026

The Scottish Medicines Consortium published advice on eight medicines on 7 September 2026. All eight were accepted:1 Eight high-cost specialist medicines accepted in a single month is an unusually high volume for the SMC. Blueteq comment: All eight medicines accepted in September would typically require prior-approval forms in a digital HCD governance system. Atidarsagene autotemcel […]

SMC Decisions — 10 August 2026

The Scottish Medicines Consortium published advice on seven medicines on 10 August 2026. All seven were accepted:  Blueteq comment:. Almost all would typically sit on Blueteq prior-approval forms in England, several under the Cancer Drugs Fund. The breadth of disease areas in a single month’s SMC decisions illustrates the scale of the managed medicines governance challenge without a digital prior-approval system.